Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

The Gap Inc. (GPS) Set to Lose in 2013

Page 1 of 2

In 2012, The Gap Inc. (NYSE:GPS) gave shareholders a staggering 67% return. While Gap’s share price soared, the company’s international operations delivered a disappointing 3% decrease in sales in 2012, adding to 2011’s woeful 7% decrease. With Gap’s big plans for 2013 focused on international expansion, I expect that international sales will continue to underperform and in the process, undermine Gap’s 2013 performance.

The Gap Inc.Plans

Gap has a strong presence in North America and Europe, as well as dozens of stores in Asia and exploratory stores in Chile, Mexico, Egypt, and South Africa. After restructuring brand management in 2012 to refocus on the international market, Gap continues to push into new markets. In 2013, the company plans to open more stores around the world, particularly in the large consumer markets of Brazil, Mexico, India, South Africa, and China. Whether Gap succeeds, flounders, or fails in these efforts will have a considerable impact on the company’s bottom line: in addition to new market research and new store expenses, Gap expects 30% of its 2013 revenue to come from international sales.


In principal, diversifying a business through sales to international markets is a no-brainer. In practice, however, every new country means a new set of business licenses, laws, and other regulations, as well as arrangements with domestic partner companies and new market research, all with no guarantee of ever making a sale.

India exemplifies this challenge. With a $500 billion domestic retail market, India holds massive potential profits for international brands. However, most have stayed out of India, citing a law that capped foreign ownership of business ventures at a 51% stake. India relaxed the law in late 2012 and dozens of companies, including Gap, immediately started exploring Indian expansions.

But as The Wall Street Journal notes, these companies are tripping over the dozens of complicating regulations still in place, some common and some country-specific, such as a law stating that 30% of a product’s value must come from Indian materials.

Additionally, Gap began planning its international expansion when markets were cheering the quick recovery and turbo growth of developing markets. The excitement cooled as GDP growth in many countries dropped off in 2012, particularly for China and Brazil. Thus, Gap is entering these markets when GDP growth may have already crested.

Finally, Gap commands high prices for its brand in developing markets. Unfortunately, Gap-branded clothing suffers from high counterfeiting rates – particularly in the larger markets it is currently targeting, like China, India, Brazil, and Mexico. Gap is not alone in high counterfeit rates, its competitor and forerunner in international markets NIKE, Inc. (NYSE:NKE) may be the most counterfeited brand in the world. However, Nike successfully campaigns against counterfeiters by detailing the performance difference between fake Nike products and authentic ones. The quality difference between fake running shoes and authentic ones is noticeable and Nike capitalizes on safety concerns, running media campaigns with national health and consumer bureaus where possible. Gap will be hard pressed to convince consumers that there is a similar difference between counterfeit jeans and authentic ones.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!